VA Launches New Psilocybin Study for Veterans With Treatment-Resistant Depression

The U.S. Department of Veterans Affairs has launched a new clinical trial to study whether psilocybin-assisted treatment can safely and effectively help veterans with treatment-resistant major depressive disorder, including veterans who also live with post-traumatic stress disorder (PTSD). The announcement, made August 4, 2026, represents a significant development in VA’s effort to evaluate new options for veterans whose mental-health symptoms have not improved with existing treatment.

For veterans, families, caregivers, and supporters in Williamson County, the key message is both hopeful and important: this is medical research conducted under structured clinical oversight. It is not a newly approved VA treatment, it does not mean psilocybin is available through routine VA care, and it is not a reason to self-medicate.

What VA Announced

The study is called Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression, or PIVOT. VA describes it as a randomized, controlled clinical trial designed to evaluate psilocybin’s effectiveness and safety for veterans diagnosed with treatment-resistant major depressive disorder, with or without concurrent PTSD.

Researchers will compare outcomes between two psilocybin dosage levels. They will assess depression symptoms before and after treatment, how well participants tolerate side effects, and veterans’ own reports of depression-related outcomes.

The trial is registered on ClinicalTrials.gov as NCT07226232.

Why This Matters

Depression and PTSD can affect every part of a veteran’s life: sleep, physical health, family relationships, employment, connection with others, and the ability to see a path forward. For some veterans, standard treatments such as therapy and medication provide meaningful relief. For others, symptoms continue despite appropriate treatment.

That is the population this study is intended to serve: veterans with treatment-resistant major depression. VA is testing whether a carefully administered treatment model could offer another evidence-based option in the future for people who have not responded sufficiently to existing care.

VA’s research program is also studying mental-health conditions such as PTSD and depression through the Million Veteran Program, with the goal of improving prevention and treatment for veterans.

What This Does Not Mean

It is important to separate legitimate clinical research from misinformation or unproven claims online.

What the PIVOT trial is	What it is not
A VA-led randomized, controlled clinical trial.	A routine or broadly available VA treatment.
A study of safety, effectiveness, side effects, and patient-reported outcomes.	Proof that psilocybin is safe or effective for every veteran.
A structured program for specifically eligible participants.	An endorsement of unsupervised use or self-treatment.
Research involving veterans with treatment-resistant major depression, with or without PTSD.	A replacement for existing mental-health care.

Psilocybin-assisted therapy research involves careful participant screening, monitored treatment sessions, and professional clinical oversight. That is fundamentally different from using substances outside a legal, medical, and research setting.

Where the Trial Will Occur

The PIVOT study will take place at five VA locations:

• Birmingham VA Health Care System in Alabama

• Tuscaloosa VA Medical Center in Alabama

• VA Portland Health Care System in Oregon

• Corporal Michael J. Crescenz VA Medical Center in Philadelphia, Pennsylvania

• VA Puget Sound Health Care System in Seattle, Washington

  
  

No Texas or Central Texas location was listed in VA’s August 4 announcement. Williamson County veterans interested in the research should avoid assuming they are eligible or that travel, enrollment, or treatment will be available locally. The official ClinicalTrials.gov listing and a qualified VA care team are the appropriate sources for participation questions.

A Broader VA Research Effort

The PIVOT announcement follows VA’s July 2026 partnership with the U.S. Department of Health and Human Services to expand research participation in potential rapid-acting mental-health treatments for veterans.

VA also announced a separate MDMA-assisted therapy clinical trial in May 2026. That study will examine safety and effectiveness for veterans with PTSD and alcohol use disorder, using a randomized, placebo-controlled design at VA Providence Healthcare System and VA Connecticut Healthcare System.

These studies are distinct. Psilocybin is being studied in PIVOT for treatment-resistant major depression, including in veterans with co-occurring PTSD; the MDMA study focuses on PTSD and alcohol use disorder.

What Veterans Can Do Now

Veterans experiencing depression, PTSD, anxiety, alcohol or substance-use concerns, or other mental-health challenges do not need to wait for research trials to seek support. VA offers mental-health services for conditions including PTSD, depression, and anxiety, with options that may include therapy, counseling, medication management, and specialty care.

Consider these steps:

• Contact your VA health-care team or local VA facility to ask about mental-health services and eligibility.

• Discuss symptoms honestly with a qualified clinician, especially if previous treatment has not provided enough relief.

• Ask about evidence-based therapies, medication options, peer support, and treatment programs appropriate to your needs.

• Use only official VA and ClinicalTrials.gov information when evaluating a clinical-study opportunity.

• Avoid products or online claims that promise a quick cure for PTSD, depression, trauma, or suicide risk. Legitimate treatment decisions should be made with qualified medical professionals.

  
  

Help in a Crisis

If you are a veteran in crisis, concerned about someone else, or experiencing thoughts of suicide, contact the Veterans Crisis Line immediately:

• Call 988, then press 1

• Text 838255

• Chat at VeteransCrisisLine.net

The Veterans Crisis Line is confidential and available 24 hours a day, 7 days a week.

WilCo Veterans’ Perspective

Veterans deserve care that is compassionate, accessible, and based on sound evidence. New research can bring hope, especially for people who have struggled to find relief through available treatments. At the same time, hope should be paired with clear information: clinical trials test possible treatments; they do not guarantee results or replace care available today.

WilCo Veterans will continue to share credible veteran-focused developments, promote connection within the Williamson County military community, and encourage veterans and families to seek qualified support when they need it.